Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-05-21 @ 11:35 AM
Study NCT ID:
NCT05970705
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2023-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC
Sponsor:
Fudan University
Organization: